Изучение воздействия рекомбинантного интерлейкина-1? человека на заживление осложненной кожной раны и язвы желудка
Диссертация
К настоящему моменту известно, что уровень IL-1 значительно повышен в нормально заживающей кожной ране (Sato Y. Ohshima T., 2000; Wang J. et al., 2009). Кроме того, известно, что IL-1 способен как прямо, так и опосредованно через индукцию синтеза других цитокинов, стимулировать пролиферативную и синтетическую активность всех основных клеточных типов, участвующих в процессе заживления кожной раны… Читать ещё >
Список литературы
- Вин Ф. Трофические язвы нижних конечностей // Флеболимфология. -1998. Т. 7. — С. 10−12.
- Аничков Н. Н., Волкова К. Г., Гаршин В. Г., Морфология заживления ран //АМН СССР. 1951. — 127с.
- Долгушина А.И. Оценка клинико-иммунологической эффективности беталейкина при лечении больных язвенной болезнью желудка и двенадцатиперстной кишки // дис. канд. мед. наук. Челябинск. 2003. -220 с.
- Ефимов Е.А. Посттравматическая регенерация кожи: монография // Е. А. Ефимов. М: «Медицина». 1975. — 168 с.
- Ефимов Е.А. О вариабельности полноты регенерации кожи //В сб. «Клеточные основы регенерации у млекопитающих». М: «Наука». 1984.- с.78−87.
- Кетлинский С.А., Симбирцев A.C. Цитокины: монография // С. А. Кетлинский, A.C. Симбирцев. СПб: ООО «Издательство Фолиант». -2008. — 552 е.: ил.
- Конусова В.Г., Симбирцев A.C., Кетлинский С. А., Влияние рекомбинантного интерлейкина l? на хемотаксическую активность нейтрофильных лейкоцитов // Вестник РАМН. 1993. — Т. 2. — С. 27.
- Пигаревский В. Е. Зернистые лейкоциты и их свойства // АМН СССР. М.- Медицина. 1978. — 126 с.
- Пигаревский П.В. Морфометрическое исследование клеток иммунорегуляторного и эффекторного звеньев иммунитета в аорте и парааортальных лимфатических узлах при атерогенезе у человека // Цитокины и Воспаление. 2002. — № 4. — С. 21−26.
- Ю.Симбирцев A.C., Пигарева Н. В., Конусова В. Г. Изучение биологической активности рекомбинантного интерлейкина-lß- человека при введении in vivo // вестник РАМН. 1993. — № 2. — С. 18−22.
- П.Симбирцев А. С. Интерлейкин-1. Физиология. Патология. Клиника: монография // А. С. Симбирцев. СПб: ООО «Издательство Фолиант». -2011.-480 е.: ил.
- Ajuebor M.N., Gibbs L., Flower R.J., Das A.M., Perretti M. Investigation of the functional role played by the chemokine monocyte chemoattractant protein-1 in interleukin-1-induced murine peritonitis // Br. J. Pharmacol. 1998. — V. 125. — P. 319−326.
- Akahoshi Т., Oppenheim J. J., Matsushima K. Interleukin-I stimulates its own receptor expression on human fibroblasts through the endogenous production of prostaglandin (s) // J. Clin. Invest. 1988. — V. 82. — P. 1219−1224.
- Andrei C., Dazzi C., Lotti L., Torrisi M.R., Chimini G., Rubartelli A. The secretory route of the leaderless protein interleukin lbeta involves exocytosis of endolysosome-related vesicles // Mol. Biol. Cell. 1999. — V. 10. — P. 14 631 475.
- Arend W.P., Joslin F.G., Massoni R.J. Effects of immune complexes on production by human monocytes of interleukin-1 or an interleukin-1 inhibitor // J. Immunol. 1985. — V. 134. — P. 3868−3875.
- Arend W.P., Smith M.F., Janson R.W., Joslin F.G. IL-1 receptor antagonist and IL-1B production in human monocytes are regulated differently // J. Immunol. 1991. — V. 147. — P. 1530−1536.
- Auron P.E., Webb A.C., Rosenwasser L.J., Mucci S.F., Rich A., Wolff S.M., Dinarello C.A. Nucleotide sequence of human monocyte interleukin 1 precursor cDNA // Proc. Natl. Acad. Sci. USA.- 1984. V. 81. P. 7907−7911.
- Auron P.E., Warner. S.J., Webb A.C., Cannon J.G., Bernheim H.A., McAdam K.J., Rosenwasser L.J., LoPreste G., Mucci S.F., Dinarello C.A. Studies on the molecular nature of human interleukin-1 // J. Immunol. 1987. — V. 138. — P. 1447. 1456.
- Bailey A.J., Bazin S., Sims T.J., Le Lous M., Nicholetis C., Delaunay A. Characterization of the collagen of human hypertrophic and normal scars // Biochim. Biophys. Acta. 1975. — V. 405. — P. 412−421.
- Bakouche O., Brown D.C., Lachman L.B. Liposomes expressing IL 1 biological activity // J. Immunol. 1987. — V. 138. — P. 4256 — 4262.
- Barnes P. J. Anti-inflammatory actions of glucocorticoids: molecular mechanisms // Clin. Sci. 1998. — V. 94. — P. 557 — 572.
- Barrientos S., Stojadinovic O., Golinko M.S., Brem H., Tomic-Canic M. Growth factors and cytokines in wound healing // Wound. Repair. Regen. -2008. -V. 16. P. 585−601.
- Baxter J.D., Forsham P.H. Tissue effects of glucocorticoids // Am. J. Med. -1972. -V. 53. P. 573 — 589.
- Beales I., Calam J. Interleukin ip and tumour necrosis factor a inhibit acid secretion in cultured rabbit parietal cells by multiple pathways // Gut. 1998. -V. 42. — P. 227−234.
- Beales I.L. Rat gastric mucosal cells express ICAM-1 and proinflammatory cytokines during indomethacin-induced mucosal injury // Life. Sci. 2004. — V. 75. — P. 2983−2995.
- Beck G., Habicht G.S., Benach J.L., Miller F. Interleukin 1: a common endogenous mediator of inflammation and the local Shwartzman reaction // J. Immunol. 1986. — V. 136. — P. 3025−3031.
- Beer H.D., Longaker M.T., Werner S. Reduced expression of PDGF and PDGF receptors during impaired wound healing // J. Invest. Dermatol. 1997. -V. 109. — P. 132−138.
- Bitar M.S. Glucocorticoid dynamics and impaired wound healing in diabetes mellitus // Am. J. Pathol. 1998. — V. 152. — P. 547−554.
- Blackwell T. S., Christman J. W. The role of Nuclear Factor-KB in cytokine gene regulation // Am. J. Respir. Cell Mol. Biol. 1997. — V. 17. — P. 3−9.
- Blyden G., Handschumacher R.E. Purification and properties of human lymphocyte activating factor (LAF) // J. Immunol. 1977. — V. 118. — P. 16 311 638.
- Brauchle M., Fassler R., Werner S. Suppression of keratinocyte growth factor expression by glucocorticoids in vitro and during wound healing // J. Invest Dermatol. 1995. — V. 105. — P. 579−584.
- Brooks P.C., Clark R.A.F., Cheresh D.A. Requirement of vascular integrin avb3 for angiogenesis // Science. 1994. — V. 264. — P. 569−571.
- Brown E.J. Phagocytosis // Bioessays. 1995. — V. 17. — P. 109 — 117.
- Brown R.L., Breeden M.P. Greenhalgh D.G. PDGF and TGF-alpha act synergistically to improve wound healing in the genetically diabetic mouse // J. Surg. Res. 1994. — V. 56. — P. 562−570.
- Butcher C., Steinkasserer A., Tejura S., Lennard A.C. Comparison of two promoters controlling expression of secreted or intracellular IL-1 receptor antagonist // J. Immunol. 1994. -V. 153. — P. 701−711.
- Chai J., Baatar D., Tarnawski A.S. Serum response factor promotes re-epithelialization and muscular structure restoration during gastric ulcer healing // Gastroenterology. 2004. — V. 126. — P. 1809−1818.
- Chedid M., Rubin J.S., Csaky K.G., Aaronson S.A. Regulation of keratinocyte growth factor gene expression by interleukin-1 // J. Biol. Chem. 1994. -V. 269. — P. 10 753−10 757.
- Chedid M., Hoyle R., Csaky G. and Rubin S. Glucocorticoids inhibit keratinocyte growth factor production in primary dermal fibroblasts // Endocrinology. 1996. — V. 137. — P. 2232−2237.
- Chen J.D., Lapier J.C., Sauder D.N. Interleukin-1-alpha stimulates keratinocyte migration through an epidermal growth factor/transforming growth factor-alpha-independent pathway // J. Invest. Dermatol. 1995. — V. 104. — P. 729 733.
- Clark R.A.F., Quinn J.H., Winn H.J., Lanigan J.M., Dellepelle P., Colvin R.B. Fibronectin is produced by blood vessels in response to injury // J. Exp. Med. -1982. -V. 156. P. 646−651.
- Clark R.A.F., Nielsen L.D., Welch M.P., McPherson J.M. Collagen matrices attenuate the collagen-synthetic response of cultured fibroblasts to TGF-b // J. Cell. Sci. 1995. — V. 108. — P. 1251−1261.
- Clark R.A.F. Wound repair. Overview and general considerations. Growth factors in wound healing // Physiol. Rev. 2003. — V. 83. In: Clark R.A.F. The Molecular and Cellular Biology of Wound Repair // New York. Plenum. Press — 1996. — P. 3−50.
- Collier S.D., Wu W.J., Pruett S.B. Endogenous glucocorticoids induced by a chemical stressor (ethanol) cause apoptosis in the spleen in B6C3F1 female mice // Toxicol. Appl. Pharmacol. 1998. V. 148(1). — P. 176−82.
- Colotta F., Re F., Mario M., Bertini R., Polentarutti N., Sironi M., Gin J., Dower S. K., Sims J.E., Mantovani A. Interleukin-I type II receptor: a decoy target for IL-I that is regulated by IL-4 // Science. -1993. V. 261. — P. 472 475.
- Corsini E., Primavera A., Marinovich M., Galli C.L. Selective induction of cell-associated interleukin-1 alpha in murine keratinocytes by chemical allergens // Toxicology. 1998. — V. 129. — P. 193−200.
- Cotran R.S., Kumar V., Robbins S.L. Gastric ulceration // Robbins Pathologic Basis of Disease. 5th Edition. Philadelphia. Saunders. 1999. — V. 298−299. -P. 773−777.
- Cranowitz E.V., Mancilla J., Clark B.D. Dinarello C.A. The IL-1 receptor antagonist inhibits IL-1 binding to thetype IIIL-I receptor // J. BioL. Chem. -1991. -V. 266. P. 14 147- 14 150.
- Cribbs R.K., Harding P.A., Luquette M.H., Besner G.E., Endogenous production of heparin-binding EGF-like growth factor during murine partial-thickness burn wound healing // J. Burn. Care. Rehabil. 2002. — V. 23. — P. 116- 125.
- Dale M., Nicklin M.J. Interleukin-1 receptor cluster: gene organization of IL1R2, IL1R1, IL1RL2 (IL-lR-rp2), IL1RL1 (T1/ST2), and IL18R1 (IL-lRrp)on human chromosome 2q // Genomics. 1999. — V.57. — P. 177−179.
- Daniel R.J., Groves R.W. Increased migration of murine keratinocytes under hypoxia is mediated by induction of urokinase plasminogen activator // J. Invest. Dermatol. 2002. — V. 119. — P. 1304−1309.
- Desmouliere A., Redard M., Darby I., Gabbiani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar // Am. J. Pathol. 1995. V. 146. — P. 56−66.
- Desmouliere A., Gabbiani G. The role of the myofibroblast in wound healing and fibrocontractive diseases. In: Clark RAF, ed. The molecular and cellular biology of wound repair. 2nd ed. New York: Plenum Press. 1996. — P. 391 423.
- Dinarello CA. Interleukin-1 and interleukin-1 antagonism// Blood. 1991. — V. 77. — P. 1627−1652.
- Dinarello C.A. IL-1: discoveries, controversies and future directions // Eur. J. Immunol. 2010. — V. 40. — P. 599−606.
- Dostal G.H., Richard L.G. The Differential Effect of Corticosteroids on Wound DisruptionStrength in Mice // Arch. Surg. 1990. — V. 125. — P. 636 640.
- Dudar G.K., DAndrea L.D., Di Stasi R., Pedone C., Wallace J.L. A vascular endothelial growth factor mimetic accelerates gastric ulcer healing in an iNOS-dependent manner // Am. J. Physiol. Gastrointest. Liver. Physiol. 2008. — V. 295. — P. 374−381.
- Eller M.S., Yaar M., Ostrom K., Harkness D.D., Gilchrest B.A. A role for interleukin-1 in epidermal differentiation: regulation by expression offunctional versus decoy receptors // J. Cell. Sci. 1995. — V. 108. — P. 27 412 746.
- El-Mahmoudy A., Shimizu Y., Shiina T., Matsuyama H., Nikami H., Takewaki T. Macrophage-derived cytokine and nitric oxide profiles in type I and type II diabetes mellitus: effect of thymoquinone // Acta. Diabetol. 2005. — V. 42. — P. 23−30.
- Falanga V., Eaglstein W.H., Bucalo B., Katz M.H., Harris B., Carson P.J. Topical use of human recombinant epidermal growth factor (h-EGF) in venous ulcers // Dermatol. Surg. Oncol. 1992. — V. 18. — P. 604−606.
- Fernandes-Alnemri T., Yu J.W., Datta P., Wu J., Alnemri E.S. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA // Nature. -2009. -V. 458. P. 509−513.
- Fink S.L., Cookson B.T. Caspase-1 -dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages // Cell. Microbiol. 2006. V. 8. — P. 1812−1825.
- Frank S., Madlener M., Werner S. Transforming growth factors (31, (32, and P3 and their receptors are differentially regulated during normal and impaired wound healing // J. Biol. Chem. 1996. — V.271. — P. 10 188 — 10 193.
- Gahring L.C., Buckley A., Daynes R.A. Presence of epidermalderived thymocyte activating factor interleukin 1 in normal human stratum corneum // J. Clin. Invest. 1985. — V. 76. — P. 1585.
- Galkowska H., Wojewodzka U., Olszewski W.L. Chemokines, cytokines, and growth factors in keratinocytes and dermal endothelial cells in the margin of chronic diabetic foot ulcers // Wound. Repair. Regen. 2006. — V. 14. — P. 558 565.
- Gamer A., Flemsirom C., Allen, A., Heyhings J. R., McQueen, S. Gastric mucosal protective mechanisms: roles of epithehial bicarbonate and mucus secretions // Scand. J. Gastroeruerol. 1984. — V. 101. — P. 79−86.
- Gao T., Lin Z., Jin X. Hydrocortisone suppression of the expression of VEGF may relate to toll-like receptor (TLR) 2 and 4 // Curr. Eye. Res. 2009. — V. 34. — P. 777−784.
- Garlick J.A., Taichman L.B. Fate of human keratinocytes during reepithelialization in an organotypic culture model // Lab. Invest. 1994. — V. 70. — P. 916−924.
- Gery I., Gershon R.K., Waksman B.H. Potentiation of the T-lymphocyte response to mitogens. I. The responding cell // J.Exp.Med. 1972. — V. 136. -P. 128−142.
- Goddard P.J., Kao Y.C. Lichtenberger M. Luminal surface hydrophobicity of canine gastric mucosa is dependent on a surface mucous gel // Gastroentenology. 1990. — V. 98. — P. 361−370.
- Goldring M.B., Krane S.M. Modulation by recombinant interleukin-1 synthesis of types I and III collagens and associated procollagen mRNA levels in cultured human cells // J. Biol. Chem. 1987. — V. 262. — P. 16 724 — 16 729.
- Granowitz E.V., Santos A.A., Poutsiaka D.D., Cannon J.G., Wilmore D.W., Wolff S.M., Dinarello C.A. Production of interleukin-1-receptor antagonist during experimental endotoxaemia // Lancet. 1991. — V. 338. — P. 1423−1424.
- Graves B. J., Hatada, M. H., Hendrickson W. A., Miller J. K., Madison V. S., Satow Y. Structure of interleukin 1 alpha at 2.7-A resolution // Biochemistry. -1990. -V. 29. P. 2679−2684.
- Greenfeder S.A., Nunes P., Kwee L., Labow M., Chizzonite R.A., Ju G. Molecular cloning and characterization of a second subunit of the interleukin-1 receptor complex // J. Biol. Chem. 1995. — V. 270. — P. 13 757−13 765.
- Greiling D., Clark R.A.F. Fibronectin provides a conduit for fibroblast transmigration from collagenous stroma into fibrin clot provisional matrix // J. Cell Sci. 1997. — V. 110. — P. 861 — 870.
- Grellner W., Georg T., Wilske J. Quantitative analysis of proinflammatory cytokines (IL-lbeta, IL-6, TNF-alpha) in human skin wounds // Forensic. Sci. Int. 2000. — V. 113. — P. 251−264.
- Grotendorst G.R., Soma Y., Takehara K., Charette M. EGF and TGF-alpha are potent chemoattractants for endothelial cells and EGF-like peptides are present at sites of tissue regeneration// J. Cell. Physiol. 1989. — V. 139. — P. 617−623.
- Gupta A., Jain K., Raghubir R. A time course study for the development of an immunocompromised wound model, using hydrocortisone // J. Pharmacol. Toxicol. 1999. — V. 41. — P. 183−187.
- Gurtner G.C., Werner S., Barrandon Y., Longaker M.T. Wound repair and regeneration//Nature. 2008. — V. 453. — P. 314−321.
- Gyulai R., Hunyadi. J., Kenderessy-Szabo A., Kemeny L., Dobozy A. Chemotaxis of freshly separated and cultured human keratinocytes // Clin. Exp. Dermatol. 1994. — V. 19. — P. 309−311.
- Harding K.G., Morris H.L., Patel G.K. Clinical review Science, medicine, and the future healing chronic wounds // B.M.J. 2002. — V. 324. — P. 160−163.
- Harvey W., Grahame R., Panayi G. S. Effects of steroid hormones on human fibroblasts in vitro. I. Glucocorticoid action on cell growth and collagen synthesis // Ann. Rheum. Dis. 1974. — V.33. — P. 437−441.
- Hashimoto I., Nakanishi H., Shono Y., Toda M., Tsuda H., Arase S. Angiostatic effects of corticosteroid on wound healing of the rabbit ear // J. Med. Invest. 2002. — V. 49. — P. 61−66.
- Hauser C., Saurat J.H. Schmitt A., Jaunin F., Dayer J. M. Interleukin-1 is present in normal human epidermis // J. Immunol. 1986. — V. 136. — P. 3317.
- Herold M.J., McPherson K.G., Reichardt H.M. Glucocorticoids in T cell apoptosis and function // Cell. Mol. Life. Sci. 2006. — V. 63. — P. 60−72.
- Hirose H., Takeuchi K., Okabe S. Effect of indomethacin on gastric mucosai blood flow around acetic acid-induced gastric ulcers in rats // Gastroenterology. 1991. — V. 100. — P. 1259.
- Hoffmann W. Regeneration of the gastric mucosa and its glands from stem cells // Curr. Med. Chem. 2008. — V. 29. — P. 3133−31.44.
- Hogquist K.A., Nett M.A., Unanue E.R., Chaplin D.D. Interleukin 1 is processed and released during apoptosis // Proc. Nat. Acad. Sci. USA. 1991. -V. 88. — P. 8485−8489.
- Hubner G., Brauchler M., Smola H., Madlener M., Fassler R., Werner S. Differential regulation of pro-inflammatory cytokines during wound healing in normal and glucocorticoid-treated mice // Cytokine. 1996. — V. 8. — P. 548 -556.
- Hull M.A., Brough J.L., Powe D.G., Carter G.I., Jenkins D., Hawkey C.J. Expression of basic fibroblast growth factor in intact and ulcerated gastric mucosa // Gut. 1998. — V. 43. — P. 525−536.
- Hurme M., Santtila S. IL-1 receptor antagonist (IL-IRa) plasma levels are co-ordinately regulated by both IL-IRa and IL-lbeta genes // Eur. J. Immunol. 1998. — V. 28. — P. 2598−2602.
- Hwang D.L., Latus L.J., Lev-Ran A. Effects of platelet-contained growth factors (PDGF, EGF, IGF-I, and TGF-beta) on DNA synthesis in porcine aortic smooth muscle cells in culture // Exp. Cell. Res. 1992. — V. 200. — P. 358−360.
- Ilan N., Mahooti S., Madri J. A. Distinct signal transduction pathways are utilized during the tube formation and survival phases of in vitro angiogenesis //J. Cell. Sci. 1998. -V. 111. — P. 3621−3631.
- Jones C.A., Seifert M.F., Dixit P.K. Macrophage migration inhibition in experimental diabetes // Proc. Soc. Exp. Biol. Med. 1982. — V. 170. P. 298 304.
- Kato K., Chen M.C., Nguyen M., Lehmann F.S., Podolsky D.K., Soil A.H. Effects of growth factors and trefoil peptides on migration and replication in primary oxyntic cultures // Am. J. Physiol. 1999. — V. 276. — P. 1105−1116.
- Kimura T., Noda M., Sugihara H., Kashima K., Hattori T. Expression of fibroblast growth factor-2 transcripts in the healing of acetic acid-induced gastric ulcers // APMIS. 1999. — V. 107. — P. 767−772.
- Koch K.C., Ye K., Clark B. D., Dinarello C.A. Interleukin 4 (IL) 4 up-regulates gene and surface IL-1 receptor type I in murine T helper type 2 cells // Eur.J. Immunol. 1992. — V. 22. — P. 153−157.
- Konturek S.J., Brzozowski T., Majka J., Pytko-Polonczyk J., Stachura J. Inhibition of nitric oxide synthase delays healing of chronic gastric ulcers // Eur. J. Pharmacol. 1993. — V. 239. — P. 215−217.
- Kumar S., Millis A. J. T. Baglioni C. Expression of interleukin-1 inducible genes and production of interleukin-1 by aging human fibroblasts. Proc. Nat. Acad. Sci. 1992. — V. 89. — P. 4683−4687.
- Kupper T. S. Immune and inflammatory processes in cutaneous tissues. is present in normal human epidermis // J. Imra. mol. 1990. — V. 136. — P. 3317.
- Kupper T.S. The activated keratinocyte: a model for inducible cytokine production by non-bone marrow-derived cells in cutaneous inflammatory and immune responses // J. Invest. Dermatol. 1990. — V. 94. — P. 146 — 150.
- Kupper T.S., Groves R.W. The interleukin-1 axis and cutaneous inflammation // J. Invest. Dermatol. 1995. — V. 105. — P. 62−66.
- Lambriola-Tomkins E., Chandran C., Varnell T. A., Madison V.S., Ju C. Structure-function analysis of human IL-la identification of residues required for binding to the human type IIL-I receptor // Protein Eng. 1993. V. 6. — P. 535−539.
- Larsen C.G., Anderson A.O., Oppenheim J. J, Matsushima K. Production of interleukin- 8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumor necrosis factor // Immunology. 1989. — V. 68. — P. 3136.
- Le J.M., Weinstein D., Gubler U., Vilcek J. Induction of membrane-associated interleukin-1 by tumor necrosis factor in human fibroblasts // J. Immunol. 1987. — V. 138. — P. 2137−2142.
- Lee B., Vouthounis C., Stojadinovic O., Brem H., Im M., Tomic-Canic M. From an enhanceosome to a repressosome: molecular antagonism between glucocorticoids and EGF leads to inhibition of wound healing // J. Mol. Biol. -2005. -V. 345. P. 1083−1097.
- Lee R.T., Briggs W.H., Cheng G.C., Rossiter H.B., Libby P., Kupper T. Mechanical deformation promotes secretion of IL-1 alpha and IL-1 receptor antagonist // J. Immunol. 1997. — V. 159. — P. 5084−5088.
- Lenco W., Mcknight M., Macdonald A.S. Effects of cortisone acetate, methylprednisolone and medroxyprogesterone on wound contracture and epithelization in rabbits // Ann. Surg. 1975. — V. 181. — P. 67−73.
- Liles W.C., Dale D.C., Klebanoff S.J. Glucocorticoids inhibit apoptosis of human neutrophils // Blood. 1995. — V. 86. — P. 3181−3188.
- Lin H., Chen B., Sun W., Zhao W., Zhao Y., Dai J. The effect of collagen-targeting platelet-derived growth factor on cellularization and vascularization of collagen scaffolds // Biomaterials. 2006. — V. 27. — P. 57 085 714.
- Lindstrom E., Lerner U.H., Hakanson R. Isolated rat stomach ECL cells generate prostaglandin E (2) in response to interleukin-1 beta, tumor necrosis factor-alpha and bradykinin // Eur. J. Pharmacol. 2001. — V. 416. -P. 255−263.
- Lipsker D., Perrigouard C., Foubert A., Cribier B. Anakinra for difficult-to-treat neutrophilic panniculitis: IL-1 blockade as a promising treatment option for neutrophil-mediated inflammatory skin disease // Dermatology. -2010. V. 220. — P. 264−267.
- Lomedico P.T., Gubler U., Hellmann C.P., Dukovich M., Giri J.G., Pan Y.C., Collier K., Semionow R., Chua A.O., Mizel S.B. Cloning and expression of murine interleukin-1 cDNA in Escherichia coli // Nature. 1984. — V. 312. -P. 458 — 462.
- Ma L., Elliott S.N., Cirino G., Buret A., Ignarro L.J., Wallace J.L. Platelets modulate gastric ulcer healing: role of endostatin and vascular endothelial growth factor release // Proc. Natl. Acad. Sci. USA.- 2001. V. 98. — P. 6470−6475.
- Maas-Szabowski N., Fusenig N.E. Interleukin-1-induced growth factor expression in postmitotic and resting fibroblasts // J. Invest. Dermatol. 1996. -V. 107. — P. 849−855.
- Maas-Szabowski N., Stark H.J., Fusenig N.E. Keratinocyte growth regulation in defined organitypic cultures through IL-1-induced keratinocyte growth factor expression in resting fibroblasts // J. Invest. Dermatol. 2000. -V. 114. — P. 1075−1084.
- Mac Kenzie A., Wilson H.L., Kiss-Toth E., Dower S.K., North R.A., Surprenant A. Rapid secretion of interleukin-1 beta by micro vesicle shedding // Immunity. 2001. — V. 15. — P. 825−835.
- Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M. The chemokine system in diverse forms of macrophage activation and polarization // Trends. Immunol. 2004. — V. 25. — P. 677−686.
- March C.J., Mosley B., Larsen A., Cerretti D.P., Braedt G., Price V., Gillis S., Henney C.S., Kronheim S.R., Grabstein K. Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs // Nature. 1985. — V. 315. — P. 641−647.
- Marks J.G., Cano C., Leitzel K., Lipton A. Inhibition of wound healing by topical steroids // J. Dermatol. Surg. Oncol. 1983. — V. 9. — P. 819−821.
- Marsh C.B., Pope H.A., Wewers M.D. Fcgamma receptor cross-linking down-regulates IL-1 receptor antagonist and induces IL-1B in mononuclear phagocytes stimulated with endotoxin or Staphylococcus aureus // J. Immunol. 1994. -V. 152. — P. 4604−4611.
- Marti G., Ferguson M., Wang J., Byrnes C., Dieb R., Qaiser R., Bonde P., Duncan M.D., Harmon J.W. Electroporative transfection with KGF-1 DNA improves wound healing in a diabetic mouse model // Gene Ther. 2004. — V. 24. — P.1780−1785.
- Martin P. Wound healing aiming for perfect skin regeneration // Science. — 1997. — V. 276. — P. 75−81.
- Masuda M., Markami T., Egawa H., Murata K. Decreased fluidity of polymorphonuclear leukocyte membrane in streptozocininduced diabetic rats // Diabetes. 1990. — V. 39. — P. 466−470.
- McCourt M., Wang J.H., Sookhai S. Proinflammatory mediators stimulate neutrophil-directed angiogenesis // Arch. Surg. 1999. — V. 134. — P. 1325−1331.
- Meszaros A.J., Reichner J.S., Albina J.E. Macrophage phagocytosis of wound neutrophils // J. Leukoc. Biol. 1999. — V. 65. — P. 35−42.
- Meszaros A.J., Reichner J.S., Albina J.E. Macrophage-induced neutrophil apoptosis // J. Immunol. 2000. — V. 165. — P. 435−441.
- Mignatti P., Rifkin D.B., Welgus H.G., Parks W.C. Proteinases and tissue remodeling. In: Clark RAF, ed. The molecular and cellular biology of wound repair. 2nd ed. New York: Plenum Press. 1996. V. 427−474.
- Mostow E. Diagnosis and classification of chronic wounds // Clin. Dermatol. 1994. — V. 12. — P.3−9.
- Murphy J.E., Robert C., Kupper T.S. Interleukin-1 and cutaneous inflammation: a crucial link between innate and acquired immunity // J. Invest. Dermatol. 2000. — V. 114. — P. 602−608.
- Myers S.R., Leigh I.M., Navsaria H. Epidermal repair results from activation of follicular and epidermal progenitor keratinocytes mediated by a growth factor cascade // Wound. Repair. Regen. 2007. — V. 15. — P. 693−701.
- Nanney L.B., King L.E. Epidermal growth factor and transforming growth factor-a // In. Clark R.A.F. The molecular and cellular biology of wound repair // New York. Plenum Press. 1996. — P. 171−94.
- Nishio N., Okawa Y., Sakurai H., Isobe K. Neutrophil depletion delays wound repair in aged mice // Age (Dordr). 2008. — V. 30. — P. 11−19.
- Nissen N.N., Polverini P.J., Koch A.E., Volin M.V., Gamelli R.L., DiPietro L.A. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing // Am. J. Pathol. 1998. — V. 152. — P. 1445 — 1452.
- Nourshargh S., Larkin S.W., Das A., Williams T.J. Interleukin-1-induced leukocyte extravasation across rat mesenteric microvessels is mediated by platelet-activating factor// Blood. 1995. — V. 85. — P. 2553−2558.
- Obminska-Domoradzka B., Szczypka M., Debowy J. Effects of thymomimetic drugs and zinc supplementation on the cellular immune response in hydrocortisone-suppressed mice // J. Vet. Med. B. Infect. Dis. Vet. Public. Health. 2002. V. 49. — P. 469−75.
- Okane S., Ferguson M.W.J. Transforming growth factors and wound healing // Int. J. Biochem. Cell. Biol. 1997. — V. 29. — 63−78.
- Olafsson R., Lancaster C., Zhang W. Interleukin-1 is cytoprotective, antisecretory, stimulates PGE2 synthesis by the stomach, and retards gastric emptying // Life. Sci. 1991. — V. 48. — P. 123−134.
- Olaru F., Jensen L.E. Staphylococcus aureus stimulates neutrophil targeting chemokine expression in keratinocytes through an autocrine IL-1 alpha signaling loop // J. Invest. Dermatol. 2010. V. — 130. — P. 1866−1876.
- Pejnovic N., Lilic D., Zunic G. et al. Abberant levels of cytokines within the healing wound after born injury // Arch. Surg. 1995. — V. 130. — P. 999 -1006.
- Pereira R.M., Freire de Carvalho J. Glucocorticoid-induced myopathy // Joint Bone Spine. 2011. — V. 78. — P. 41−44.
- Perez-Ruiz M., Ros J., Morales-Ruiz M., Navasa M., Colmenero J., Ruiz-del-Arbol L., Cejudo P., Claria J., Rivera F., Arroyo V., Rodes J.,
- Jimenez W. Vascular endothelial growth factor production in peritoneal macrophages of cirrhotic patients: regulation by cytokines and bacterial lipopolysaccharide // Hepatology. 1999. — V. 29. — P. 1057−1063.
- Piasecki C. Evidence for an infarctive pathogenesis of acute and chronic gastroduodenal ulceration // J. Physiol. Pharmacol. 1992. — V. 43. — P. 99−113.
- Piazuelo E., Lanas A., Jimenez P., Garcia-Gonzalez A., Esteva F. In vitro wound repair by human gastric fibroblasts: implications for ulcer healing // Dig. Dis. Sci. 1998. — V. 43. — P. 1230−1240.
- Pintucci G., Bikfalvi A., Klein S., Rifkin D.B. Angiogenesis and the fibrinolytic system// Semin. Thromb. Hemost. 1996. — V. 22. — P. 517−524.
- Poeck H., Bscheider M., Gross O., Finger K., Roth S., Rebsamen M. Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production // Nat. Immunol. -2010. -V. 11. P. 63−69.
- Pollack S.V. Systemic medications and wound healing // Int. J. Dermatol. 1982. — V. 21. — P. 489 — 496.
- Priestle H.P., Schar H.P., Grutter M.G. Crystal structure of the cytokine interleukin-lp // EMBO J. 1988. — V. 7. — P. 339 — 343.
- Qu Y., Franchi L., Nunez G., Dubyak G.R. Nonclassical IL-1 beta secretion stimulated by P2X7 receptors is dependent on inflammasome activationand correlated with exosome release in murine macrophages // J. Immunol. 2007. V. 179. — P. 1913−1925.
- Raines E.W., Dower S.K., Ross R. Interleukin-1 mitogenic activity for fibroblasts and smooth muskle cells is due to PDGF // Science. 1989. — V. 243. — P. 393 — 394.
- Ramalingam A., Hirai A., Thompson E.A. Glucocorticoid inhibition of fibroblast proliferation and regulation of the cyclin kinase inhibitor p21Cipl // Mol. Endocrinol. 1997. — V. 11. — P. 577−586.
- Rappolee D.A., Mark D., Banda M.J., Werb Z. Wound macrophages express TGF-a and other growth factors in vivo: analysis by mRNA phenotyping// Science. 1988. — V. 241. — P. 708−12.
- Rennekampff H.O., Hansbrough J.F., Kiessig V. Bioactive interleukin-8 is expressed in wounds and enhances wound healing // J. Surg. Res. 2000. -V. 93.-P. 41−54.
- Richard K.A., Yem A.W., Deibel M.R., Staite N.D. Isolation and bioactivities of three IL-1 beta N-terminal variants // Agents Actions. 1989. -V. 27. — P. 268−270.
- Riches D.W.F. The multiple role of macrophages in wound healing. In: Clark R.A.F., Henson P.M. The molecular and cell biology of wound repair. // New York. Premium Press. 1998. — P. 213 — 242.
- Roberts A.B., Sporn M.B. Transforming growth factor In: The Molecular and Cellular Biology of Wound Repair (2nd ed.), edited by Clark R.A.F. New York: Plenum. 1996. — P. 275−308.
- Rolfe K.J., Richardson J., Vigor C., Irvine L.M., Grobbelaar A.O., Linge C. A role for TGF-betal-induced cellular responses during wound healing of the non-scarring early human fetus // J. Invest. Dermatol. 2007. — V. 127. — P. 2656−2667.
- Romero L.I., Zhang D.N., Herron G.S., Karasek M.A. Interleukin-1 induces major phenotypic changes in human skin microvascular endothelial cells // J. Cell. Physiol. 1997. V. 173. — P. 84−92.
- Rubartelli A., Cozzolino F., Talio M., Sitia R.A. Novel secretory pathway for interleukin-1 beta, a protein lacking a signal sequence // EMBO J.- 1990. -V. 9. P. 1503 — 1510.
- Russel S.B., Trupin J.S., Myers J.C. Differential glucocorticoid regulation of collagen mRNAs in human dermal fibroblasts // J. Biol. Chem. -1989. V. 264. — P. 13 730−13 735.
- Saaristo A., Tammela T., Farkkila A., Karkkainen M., Suominen E., Yla-Herttuala S., Alitalo K. Vascular endothelial growth factor-C accelerates diabetic wound healing // Am. J. Pathol. 2006. — V. 169. — P. 1080−1087.
- Saffar A.S., Ashdown H., Gounni A.S. The molecular mechanisms of glucocorticoids-mediated neutrophil survival // Curr. Drug. Targets. 2011. -V. 12. — P. 556−562.
- Salo T., Makela M., Kylmaniemi M., Autio-Harmainen H., Larjava H. Expression of matrix metalloproteinase-2 and -9 during early human wound healing // Lab. Invest. 1994. — V. 70. — P. 176 — 182.
- Sasaki T. The effects of basic fibroblast growth factor and doxorubicin on cultured human skin fibroblasts: relevance to wound healing // J. Dermatol.- 1992. -V. 19. P. 664−666.
- Sato Y., Ohshima T. The expression of mRNA of proinflammatory cytokines during skin wound healing in mice: a preliminary study for forensic wound age estimation (II) // Int. J. Legal. 2000. — V. 113. — P. 140−145.
- Sauder D.N., Kilian P.L., McLane J.A., Quick T.W., Jakubovic H., Davis S.C., Eaglstein W.H., Mertz P.M. Interleukin-1 enhances epidermal wound healing // Lymphokine. Res. 1990. — V. 9. — P. 465−473.
- Scapigliati, C., Chiara P., Bartalini A., Taglibue A., Boraschi D. Differential binding of IL-ia and IL-ifl to receptors onB and T cells // FEBS. Lett. 1989. — V. 243. — P. 394−398.
- Schepp W., Dehne K., Herrmuth H., Pfeffer K., Prinz C. Identification and functional importance of IL-1 receptors on rat parietal cells // Am. J. Physiol. 1998. — V. 275. — P. 1094−1105.
- Schindler R., Clark B.D., Dinarello C.A. Dissociation between interleukin-lfl mRNa and protein synthesis in human peripheral blood mononuclear cells // J. Biol. Chem. 1990. V. 265. — P. 10 232−10 237.
- Schroder K., Tschopp J. The inflammasomes // Cell. 2010. — V. 140. -P. 821−832.
- Schultz G. S,. White M,. Mitchell R,. Brown G,. Lynch J,.Twardzik D. R,. Todaro G. J, Epithelial wound healing enhanced by transforming growth factor-alpha and vaccinia growth factor // Science. 1987. — V. 235. — P. 350- 352.
- Seckinger P., Williamson K., Balavoine J.F., Mach B., Mazzei G., Shaw A., Dayer J.M. A urine inhibitor of interleukin-1 activity affects both interleukin-1 alpha and lbeta but not tumor necrosis factor alpha // J. Immunol. 1987. -V. 139. — P. 1541.
- Shah M., Foreman D.M., Ferguson M.W. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring // J. Cell. Sci. 1995. — V. 108. — P. 985−1002.
- Shull S., Meisler N., Absher M., Phan S., Cutroneo K. Glucocorticoid-induced down regulation of transforming growth factor in adult rat lung fibroblasts // Lung. 1995. — V. 173. — P. 71−78.
- Sieggreen M.Y., Kline R.A. Vascular ulcers. In: Baranoski S., Ayello E.A. Wound Care Essentials: Practice Principles. Philadelphia, PA: Lippincott Williams & Wilkins- 2004. — P. 271−310.
- Silen W., Ito. S. Mechanisms for rapid re-epithelialization of thegastric mucosal surface // Annu. Rev. Physiol. 1985. — V. 47. — P. 217−229.
- Simbirtsev A.S., Pigareva V.G., Kalinina N.M., Sorokin E.M., Ketlinskii S.A. The biological activity of human recombinant interleukin-1 beta when administered in vivo // Vestn. Ross. Akad. Med. Nauk. 1993. — V. 2. — P. 1822.
- Sims J. E., Ciri J.C., Dower S.K. The two interleukin-1 receptors play different roles in I-i activities // Clin. Immunol. Immunopathol. 1994. — V. 72. -P. 9−14.
- Singer A. J., Clark R. A. F. Cutaneous wound healing // New. Engl. J. Med. 1999. — V. 341. — P. 738 — 746.
- Smith L.K., Shah R.R., Cidlowski J.A. Glucocorticoids modulate microRNA expression and processing during lymphocyte apoptosis // J. Biol. Chem. 2010. — V. 285. — P. 36 698−36 708.
- Spravchikov N., Sizyakov G., Gartsbein M., Accili D., Tennenbaum T., Wertheimer E. Glucose effects on skin keratinocytes implications for diabetes skin complications // J. Diabetes. 2001. — V. 50. — P. 1627−1635.
- Stanley A.C., Park H.Y., Phillips T.J., Russakovsky V., Menzoian J.O. Reduced growth of dermal fibroblasts from chronic venous ulcers can be stimulated with growth factors // J. Vase. Surg. 1997. — V. 26. — P. 994−1001.
- Steed D.L. Diabetic Ulcer Study Group Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers // J. Vase. Surg. 1995. — V. 21. — P. 71−81.
- Stephens F.O., Dunphy J.E., and Hunt T.K. Effect of delayed administration of corticosteroids on wound contraction // Ann. Surg. 1971. -V. 173. — P. 214−218.
- Sticherling M., Borascheur E., Schroder M., Cristopher E. Immunihistochemical study of NAP/ interleukin-8 in contact ekzema and atopic dermatitis. // Arch. Dermatol. Res. 1992. — V. 284. — P. 82 — 85.
- Stossel T.P. On the crawling of animal cells // Science. 1993. — V. 260. -P. 1086−1094.
- Strieter R. M., Kasahara K. Allen R. M., Standiford T. J., Rolfe M. W., Becker F. S., Chensue S. W., Kunkel S. L. Cytokine-induced neutrophil-derived interleukin-8 // Am. J. Pathol. 1992. — V. 141. — P. 397 — 407.
- Stylianou E., O’Neill L.A., Rawlinson L., Edbrooke M.R., Woo P., Saklatvala J. Interleukin 1 induces NF-kappa B through its type I but not its type II receptor in lymphocytes // J. Biol. Chem. 1992. — V. 267. — P. 15 836 -15 841.
- Szabo S., Folkman J., Vattay P. Accelerated healing of duodenal ulcers by oral administration of basic fibroblast growth factors in rats // Gastroenterology. 1994. — V. 106. — P. 1106−1111.
- Szabo S., Folkman J., Vincze A., Sandor Z.S., Gombos A. Modulation of vascular factors by VEGF/VPF is sufficient for chronic ulcer healing and acute gastroprotection // Gastroenterology. 1997. — V. 122. — P. 303.
- Takahashi S., Shigeta J., Inoue H., Tanabe T., Okabe S. Localization of cyclooxygenase-2 and regulation of its mRNA expression in gastric ulcers in rats // Am. J. Physiol. 1998. — V. 275. — P. 1137−1145.
- Takahashi S., Kobayashi N., Okabe S. Regulation by endogenous interleukin-1 of mRNA expression of healing-related factors in gastric ulcers in rats // J. Pharmacol. Exp. Ther. 1999. — V. 291. — P. 634−641.
- Takami Y, Motoki T, Yamamoto I, Gohda E. Synergistic induction of hepatocyte growth factor in human skin fibroblasts by the inflammatory cytokines interleukin-1 and interferon-gamma // Biochem. Biophys. Res. Commun. 2005. — V. 327. — P. 212−217.
- Tanigawa T., Pai R., Arakawa T., Higuchi K., Tarnawski A. TGF-beta signaling pathway: its role in gastrointestinal pathophysiology and modulation of ulcer healing // J. Physiol. Pharmacol. 2005. — V. 56. — P. 3−13.
- Tarnawski A. Cellular mechanisms of gastric ulcer healing. In The Stomach. Domschke W., Konturek S.J. (eds). Berlin New York, Springer. -1993. P. 177−192.
- Tarnawski A. Molecular mechanism of ulcer healing // Drug. News. Perspect. 2000. — V. 13. — P. 158−168.
- Tarnawski A., Szabo I.L., Husain S.S., Soreghan B. Regeneration of gastric mucosa during ulcer healing is triggered by growth factors and signal transduction pathways // J. Physiol. Paris. 2001. — V. 95. — P. 337−344.
- Taylor S.L., Renshaw B.R., Garka K.E., Smith D.E., Sims J.E. Genomic organization of the interleukin-1 locus // Genomics. 2002. — V. 79. — P.726−733.
- Terashi H., Izumi K., Deveci M., Rhodes L.M., Marcelo C.L. High glucose inhibits human epidermal keratinocyte proliferation for cellular studies on diabetes mellitus // Int. Wound. J. 2005. — V. 2. — P. 298−304.
- Tetreault M.P., Chailler P., Rivard N., Menard D. Differential growth factor induction and modulation of human gastric epithelial regeneration // Exp. Cell. Res. 2005. — V. 306. — P. 285−297.
- Thornberry N.A., Bull H.G., Calaycay J.R., Chapman K.T., Howard A.D., Kostura M.J. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes // Nature. 1992. — V. 356 — P. 768 774.
- Tomic-Canic M., Komine M., Freedberg I.M., Blumenberg M. Epidermal signal transduction and transcription factor activation in activated keratinocytes // J. Dermatol. Sci. 1998. — V. 17. — P. 167−181.
- Tominaga K., Arakawa T., Kim S., Iwao H., Kobayashi K. Increased expression of transforming growth factor-beta 1 during gastric ulcer healing in rats // Dig. Dis. Sci. 1997. — V. 42. — P. 616−625.
- Tsuboi R., Sato C., Kurita Y., Ron D., Rubin J.S., Ogawa H. Keratinocyte growth factor (FGF-7) stimulates migration and plasminogen activator activity of normal human keratinocytes // J. Invest Dermatol. 1993. -V. 101. — P. 49−53.
- Tsukimi Y., Okabe S. Effect of anterior unilateral vagotomy on healing of kissing gastric ulcers induced in rats // Jpn. J. Pharmacol. 1994. — V. 66. -P. 105−114.
- Tsukimi Y., Nakai H., Itoh S. Involments of heat shok proteins in the healing of acetic acid-induced gastric ulcers in rats // J. Physiol. Pharmacol. -2001. -V. 52. P. 391−406.
- Ucla C., Roux-Lombard P., Fey S., Dayer J.M., Mach B. Interferon gamma drastically modifies the regulation of interleukin-1 genes by endotoxin in U937 cells // J. Clin. Invest. 1990. — V. 85. — P. 185−191.
- Usui M.L., Mansbridge J.N., Carter W.G., Fujita M., Olerud J.E. Keratinocyte migration, proliferation, and differentiation in chronic ulcers from patients with diabetes and normal wounds // J. Histochem. Cytochem. 2008. -V. 56. — P. 687−696.
- Vigers C. P., Caffes P., Evans R.J., Thompson R.C., Eisenberg S.P., Brandhuber B.J. X-ray structure of interleukin-1 receptor antagonist at 2.0-A resolution // J. Biol. Chem. 1994. — V. 269. — P. 12 874−12 879.
- Wahl S. M., Schleimer R. P., Claman H. N., Oronsky A.L. Glucocorticoids and wound healing // Anti-inflammatory Steroid Action. Basic and Clinical Aspects Eds. Academic Press, San Diego. 1989. — P. 280−302.
- Wallace J. L. Gastric resistance to acid: is the «mucus-bicarbonate barrier» functionally redundant? // Am. J. Physiol. 1989. — V. 256. — P. 31−38.
- Wallace J.L., McKnight C. W. The mucoid cap over superficial gastric damage in the rat. A high-pH microenvironment dissipated by nonsteroids! antiinflammatory drugs and endothelin // Gastroentemlogy. 1990. V. 99. — P. 295−304.
- Wallace J.L., Cucala M., Mugridge K., Parente L. Secretagogue-specific effects of interleukin-1 on gastric acid secretion // Am. J. Physiol. 1991. — V. 261. — P. 559−564.
- Wallace J.L., Dicay M., McKnight W., Dudar G.K. Platelets accelerate gastric ulcer healing through presentation of vascular endothelial growth factor // Br. J. Pharmacol. 2006. — V. 148. — P. 274−278.
- Wang J.F., Olson M.E., Reno C.R., Kulyk W., Wright J.B., Hart D.A. Molecular and cell biology of skin wound healing in a pig model // Connect. Tissue Res. 2009. — V. 41. — P. 195−211.
- Warner S.J., Auger K.R., Libby P. Interleukin 1 induces interleukin-1. II. Recombinant human interleukin-1 induces interleukin-1 production by adult human vascular endothelial cells // J. Immunol. 1987. — V. 139. — P. 19 111 917.
- Watanabe N., Kobayashi Y. Related Selective release of a processed form of interleukin 1 alpha // Cytokine. 1994. — V. 6. — P. 597−601.
- Watanabe S., Hirose M., Wang X.E., Maehiro K., Murai T., Kobayashi O., Nagahara A., Sato N. Hepatocyte growth factor accelerates the wound repair of cultured gastric mucosal cells // Biochem. Biophys. Res. Commun. -1994. -V. 199. P. 1453−1460.
- Watanabe S., Hirose M., Wang X.E., Kobayashi O., Nagahara A., Murai T., Iwazaki R., Miwa H., Miyazaki A., Sato N. Epithelial-mesenchymalinteraction in gastric mucosal restoration // J. Gastroenterol. 2000. — V. 35. -P. 65−68.
- Weitzmann M.N., Savage N. Nuclear internalisation and DNA binding activities of interleukin-1, interleukin-1 receptor and interleukin-1/receptor complexes // Biochem. Biophys. Res. Commun. 1992. — V. 187. — P. 11 661 171.
- Werner S., Smola H., Liao X. The function of KGF in morphogenesis of epithelium and reepithelialization of wounds // Science. 1994. — V. 266. — P. 819−22.
- Werner S., Breeden M., Hiibner G., Greenhalgh D.G., Longaker M.T. Induction of keratinocyte growth factor expression is reduced and delayed during wound healing in the genetically diabetic mouse // J. Invest. Dermatol. -1994. V. 103. — P. 469−473.
- Werner S. Keratinocyte growth factor: a unique player in epithelial repair processes // Cytokine Growth Factor Rev. 1998. — V. 2. — P. 153−165.
- Werner S., Smola H. Paracrine regulation of keratinocyte proliferation and differentiation // Trends. Cell. Biol. 2001. — V. 11. — P. 143−146.
- Werner S., Grose R. Regulation of wound healing by growth factors and cytokines // Physiol. Rev. 2003. V. 83. — P. 835−870.
- Witowski J., Tayama H., Ksiazek K., Wanic-Kossowska M., Bender T.O., Jorres A. Human peritoneal fibroblasts are a potent source of neutrophil-targeting cytokines: a key role of IL-lbeta stimulation // Lab. Invest. 2009. -V. 89. — P. 414−424.
- Wong W.M., Playford R.J., Wright N.A. Peptide gene expression in gastrointestinal mucosal ulceration: ordered sequence or redundancy // Gut. -2000. V. 46. — P. 286−292.
- Wright N. A. Role of mucosal cell renewal in mucosal protection in the gastrointestinal tract // Mechanisms of Mucosal Protection in the Upper Gastrointestinal Tract. Raven Press, New York. 1984. — P. 15−20.
- Wright N.A., Pike C., Elia G. Induction of a novel epidermal growth factor-secreting cell lineage mucosal ulceration in human gastrointestinal stem cells //Nature. 1990. — V. 343. — P. 82−85.
- Wyble C.W., Hynes K.L., Kuchibhotla J., Marcus B.C., Hallahan D., Gewertz B.L. TNF-alpha and IL-1 upregulate membrane-bound and soluble E-selectin through a common pathway // J. Surg. Res. 1997. V. 73. — P. 107 112.
- Xu C., He J., Jiang H., Zu L., Zhai W., Pu S., Xu G. Direct Effect of Glucocorticoids on Lipolysis in Adipocytes // Molecular Endocrinology. -2009. V. 23. P. 1161−1170.
- Yano S., Banno T., Walsh R., Blumenberg M. Transcriptional responses of human epidermal keratinocytes to cytokine interleukin-1 // Journal of Cellular Physiology. 2008. — V. 214. — P. 1−13.
- Yarwood H., Nourshargh S., Brain S., Williams T.J. Effect of dexamethasone on neutrophil accumulation and oedema formation in rabbit skin: an investigation of site of action // Br. J. Pharmacol. 1993. — V. 108. P. 959−966.
- Yoshida S., Matsumoto K., Tomioka D., Bessho K., Itami S., Yoshikawa K., Nakamura T. Recombinant hepatocyte growth factor accelerates cutaneouswound healing in a diabetic mouse model // Growth Factors. 2004. — V. 22. -P. 111−119.
- Zepter K., Haffner A., De Soohoo L.F. Induction of biologically active IL-1 beta-converting enzyme and mature IL-1 beta in human keratinocytes by inflammatory and immunologic stimuli // J. Immunol. 1997. — V. 159. — P. 6203−6208.
- Zimecki M., Schnaper H.W., Wieczorek Z., Webb D.R., Pierce C.W. Inhibition of interleukin 1 (IL-l)-elicited leukocytosis and LPS-induced fever by soluble immune response suppressor (SIRS) // Immunopharmacology. -1990. -V. 19. P. 39−46.
- Zykova S.N., Jenssen T.G., Berdal M., Olsen R., Myklebust R., Seljelid R. Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice // Diabetes. 2000. — V. 49. — P. 1451−1458.